Matches in Nanopublications for { ?s ?p "[TERC is a likely target of the 3q26 amplification, and, therefore, may be a useful biomarker for diagnosis and an attractive, novel target for molecular therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP727708.RAVmAIKTUi9vbpeYMjaJD_KEE2gv4fAN5Sa67ZCRxHC0c130_assertion description "[TERC is a likely target of the 3q26 amplification, and, therefore, may be a useful biomarker for diagnosis and an attractive, novel target for molecular therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727708.RAVmAIKTUi9vbpeYMjaJD_KEE2gv4fAN5Sa67ZCRxHC0c130_provenance.
- assertion description "[TERC is a likely target of the 3q26 amplification, and, therefore, may be a useful biomarker for diagnosis and an attractive, novel target for molecular therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_assertion description "[TERC is a likely target of the 3q26 amplification, and, therefore, may be a useful biomarker for diagnosis and an attractive, novel target for molecular therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418411.RA_Ym460AvdMSClK0TQz3BW1QOxgpP4Rlc-mkKIvj7VXY130_provenance.